Lv5
860 积分 2024-10-23 加入
Metabolic reprogramming in septic acute kidney injury: pathogenesis and therapeutic implications
4天前
已完结
Macrophage-targeted mannose-decorated PLGA-vegetable oil hybrid nanoparticles loaded with anti-inflammatory agents
1个月前
已完结
HIF-1α inducing exosomal microRNA-23a expression mediates the cross-talk between tubular epithelial cells and macrophages in tubulointerstitial inflammation
1个月前
已完结
Thirty years of NRF2: advances and therapeutic challenges
1个月前
已完结
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial
8个月前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
8个月前
已完结
The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy
8个月前
已关闭
皖公网安备34019202002308
